Company intelligence / Profile preview
Biozeus
Unknown, Unknown, Brazilbiozeus.com.br ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Biozeus is currently developing several drug candidates with BZ-371A for erectile dysfunction being the most advanced (Phase 2). Other programs include BZ043 for diabetes (Preclinical) and several discontinued programs.
- Therapeutic areas
- Men's HealthEndocrinologyPulmonology
- Modalities
- Synthetic peptides
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Collaborations with Brazilian research institutions
Beyond the preview
Go deeper on Biozeus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biozeus.